- Home
- PLTK vs IDYA Comparison
PLTK vs IDYA Comparison
Compare PLTK & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLTK
- IDYA
- Stock Information
- Founded
- PLTK 2010
- IDYA 2015
- Country
- PLTK Israel
- IDYA United States
- Employees
- PLTK N/A
- IDYA N/A
- Industry
- PLTK EDP Services
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- PLTK Technology
- IDYA Health Care
- Exchange
- PLTK Nasdaq
- IDYA Nasdaq
- Market Cap
- PLTK 2.0B
- IDYA 1.9B
- IPO Year
- PLTK 2021
- IDYA 2019
- Fundamental
- Price
- PLTK $4.97
- IDYA $21.63
- Analyst Decision
- PLTK Buy
- IDYA Strong Buy
- Analyst Count
- PLTK 7
- IDYA 13
- Target Price
- PLTK $7.68
- IDYA $53.42
- AVG Volume (30 Days)
- PLTK 1.6M
- IDYA 1.1M
- Earning Date
- PLTK 08-06-2025
- IDYA 08-05-2025
- Dividend Yield
- PLTK 8.39%
- IDYA N/A
- EPS Growth
- PLTK N/A
- IDYA N/A
- EPS
- PLTK 0.37
- IDYA N/A
- Revenue
- PLTK $2,604,100,000.00
- IDYA $7,000,000.00
- Revenue This Year
- PLTK $13.29
- IDYA $101.20
- Revenue Next Year
- PLTK $3.91
- IDYA $286.70
- P/E Ratio
- PLTK $12.73
- IDYA N/A
- Revenue Growth
- PLTK 1.64
- IDYA N/A
- 52 Week Low
- PLTK $3.97
- IDYA $13.45
- 52 Week High
- PLTK $8.80
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- PLTK 49.94
- IDYA 47.71
- Support Level
- PLTK $4.64
- IDYA $21.08
- Resistance Level
- PLTK $4.90
- IDYA $22.86
- Average True Range (ATR)
- PLTK 0.14
- IDYA 0.89
- MACD
- PLTK 0.02
- IDYA -0.24
- Stochastic Oscillator
- PLTK 63.03
- IDYA 12.76
About PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.